WC
IDXX icon

Waterloo Capital’s Idexx Laboratories IDXX Stock Holding History

Waterloo Capital’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-392
Closed -$220K – 576
2026
Q1 		$220K Buy
392
+44
+13% +$28.2K 0.02% 453
2025
Q4 		$235K Sell
348
-10
-3% -$6.81K 0.02% 422
2025
Q3 		$229K Sell
358
-84
-19% -$51K 0.02% 415
2025
Q2 		$237K Buy
+442
New +$211K 0.02% 408

Other funds holding IDXX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Waterloo Capital's IDXX Position: Q2 2026 in Review

Waterloo Capital sold out of Idexx Laboratories (IDXX) in Q2 2026, closing a stake of 392 shares — an estimated $220K sold.

Waterloo Capital first reported a position in IDXX in Q2 2025 and held it in 4 quarters. The position peaked at $237K in Q2 2025. 1,302 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Waterloo Capital reported no remaining Idexx Laboratories position as of Q2 2026 after selling out during the quarter.
  • Waterloo Capital sold 392 Idexx Laboratories shares in Q2 2026, an estimated $220K.
  • Waterloo Capital first reported a position in Idexx Laboratories in Q2 2025 and held it in 4 quarters.
  • Waterloo Capital's Idexx Laboratories position peaked at $237K in Q2 2025.
  • 1,302 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Waterloo Capital's 13F filing for Q2 2026, filed 29 Jul 2026.